Follicular Thyroid Cancer: Clinical Trials

1 trial for Follicular Thyroid Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow Follicular Thyroid Cancer: new trials by email Literature Review of Follicular Thyroid Cancer trials Research Report on Follicular Thyroid Cancer

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Drug-Drug Interaction Study of the Effects of XL184 (Cabozantinib) on Rosiglitazone in Subjects With Solid Tumors
rosiglitazone, XL184 - Papillary Thyroid Cancer, Follicular Thyroid Cancer
Phase 1CompletedExelixis402010-04-012013-09-19

Narrower conditions

Adenocarcinoma, Follicular (1)  ·  Carcinoma, Renal Cell (1)  ·  Thyroid Cancer, Papillary (1)

Broader conditions

Adenocarcinoma (1)  ·  Adenocarcinoma, Papillary (1)  ·  Carcinoma (1)  ·  Endocrine Gland Neoplasms (1)  ·  Endocrine System Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Head and Neck Neoplasms (1)  ·  Kidney Diseases (1)  ·  Kidney Neoplasms (1)  ·  Male Urogenital Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)  ·  Neoplasms, Glandular and Epithelial (1)

Interventions

Rosiglitazone (1)

Sponsors

Exelixis (1)

Countries

United States (1)

Results publications

PMID 24827131